Fixed Drug Eruption in an Epileptic Patient Previously Receiving Treatment With Phenytoin for Seven Years
A 52-year-old African American female presented with severe left thigh pain of unknown etiology. She had a past medical history of generalized seizure disorder treated with phenytoin for 7 years without incident. During admission a nurse witnessed a seizure, and consequently loading and maintenance...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2013-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_8b1d699ac10b40c19e3c61b65e88416b | ||
042 | |a dc | ||
100 | 1 | 0 | |a Keaton S. Smetana |e author |
700 | 1 | 0 | |a Katie J. Suda PharmD, MS |e author |
700 | 1 | 0 | |a Leslie A. Hamilton PharmD |e author |
245 | 0 | 0 | |a Fixed Drug Eruption in an Epileptic Patient Previously Receiving Treatment With Phenytoin for Seven Years |
260 | |b SAGE Publishing, |c 2013-11-01T00:00:00Z. | ||
500 | |a 2324-7096 | ||
500 | |a 10.1177/2324709613512622 | ||
520 | |a A 52-year-old African American female presented with severe left thigh pain of unknown etiology. She had a past medical history of generalized seizure disorder treated with phenytoin for 7 years without incident. During admission a nurse witnessed a seizure, and consequently loading and maintenance doses of phenytoin were administered to obtain a therapeutic serum concentration. The patient had a history of noncompliance with multiple subtherapeutic phenytoin levels. Subsequently, unifocal blue discolored spots appeared, progressing to a bullous component that was positive for skin sloughing. Drug-induced fixed drug eruption was diagnosed and attributed to phenytoin. Clinicians should be cognizant of drug-induced fixed drug eruption in patients just initiated and those receiving long-term treatment with phenytoin. The administration rate of phenytoin may be associated with the development of fixed drug eruption. | ||
546 | |a EN | ||
690 | |a Medicine (General) | ||
690 | |a R5-920 | ||
690 | |a Pathology | ||
690 | |a RB1-214 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Investigative Medicine High Impact Case Reports, Vol 1 (2013) | |
787 | 0 | |n https://doi.org/10.1177/2324709613512622 | |
787 | 0 | |n https://doaj.org/toc/2324-7096 | |
856 | 4 | 1 | |u https://doaj.org/article/8b1d699ac10b40c19e3c61b65e88416b |z Connect to this object online. |